via Smithsonian Magazine
For women, mammograms are a sometimes uncomfortable, but necessary, annual ritual. But this procedure doesn’t always provide accurate results, and it exposes women to X-rays. In a study appearing in ACS’ journal MolecularPharmaceutics, scientists report that they have developed a non-invasive “disease screening pill” that can make cancerous tumors light up when exposed to near-infrared light in mice without using radiation.
Breast cancer is the second most common cancer in women, according to the American Cancer Society. Mammograms are X-rays of breast tissue that can provide information about a lump’s location and size, but they can’t distinguish between cancerous and benign growths. As a result, up to one in three healthy women undergo unnecessary breast cancer treatments and procedures, according to a recent study by researchers in Denmark. Mammograms also require low levels of radiation. While risk of harm from this exposure is minimal, repeated X-rays can potentially cause health issues. Fluorescent probes can detect breast tumors, but they must be given intravenously. So, Greg M. Thurber and colleagues set out to develop a more accurate, safer technique that was also non-invasive.
The researchers combined two types of molecules into a single pill: a targeting molecule that binds to proteins on the surface of breast cancer cells; and a dye that had negatively charged sulfate groups attached to it. Sulfate groups enhance the solubility of near-infrared florescent dyes, increasing the likelihood of detecting the tumor. Testing in mice showed that with this formulation, a considerable proportion of the imaging agent was absorbed into the bloodstream. It also bound specifically to cancer cells with little background noise. The researchers say that the pill could lead to an accurate, safe and noninvasive way to detect breast cancer, and it could be modified in the future to detect other diseases.
Learn more: Diagnosing breast cancer with an imaging pill
The Latest on: Imaging pill
via Google News
The Latest on: Imaging pill
- Smart Pills Market By Top Leading Players CapsoVision, Inc., Given Imaging, Inc., Boston Scientific Corporation, Proteus Digital Health, Medtronic on November 29, 2018 at 2:17 am
The Exclusive Smart Pills Market report provides the details related to fundamental Smart Pills overview, development status, Growth opportunity, technological advancements, market dominance and marke... […]
- Harvard-AKU collaboration brings unique imaging ‘pill’ to Karachi on June 22, 2018 at 1:48 am
KARACHI: Aga Khan University researchers have partnered with faculty at the Massachusetts General Hospital in the US, an affiliate of Harvard Medical School, to test a novel pill-shaped imaging device ... […]
- Diagnosing breast cancer with an imaging pill on May 15, 2018 at 5:00 pm
For women, mammograms are a sometimes uncomfortable, but necessary, annual ritual. But this procedure doesn’t always provide accurate results, and it exposes women to X-rays. In a study appearing in A... […]
- Flourescent Camera Pill Could Hunt for Cancer in Your Guts on March 14, 2016 at 8:00 am
Illustration: University of Glasgow An illustration of the components making up the video pill that uses fluorescent imaging. Altogether, the tiny capsule consumes only 30.9 milliwatts of power in use ... […]
- Given Imaging Pill Camera Approved for Colorectal Cancer Screenings on February 4, 2014 at 9:44 pm
Given Imaging’s PillCam COLON was approved for colorectal cancer screenings in the U.S. based on a clinical trial conducted on 884 patients at 16 sites to assessed the safety and effectiveness in dete... […]
- Given Imaging gets FDA clearance for colon camera pill on February 3, 2014 at 12:27 am
JERUSALEM, Feb 3 (Reuters) - Camera-in-a-pill maker Given Imaging said on Monday it received U.S. Food and Drug Administration clearance for a pill to provide visualisation of the colon that has a glo... […]
- Covidien buys camera-in-a-pill maker Given Imaging for $860 mln on December 8, 2013 at 12:46 am
TEL AVIV, Dec 8 (Reuters) - Medical device maker Covidien PLC will acquire Israeli camera-in-a-pill maker Given Imaging for $30.00 per share in cash, or a total of $860 million, the companies said on ... […]
- Israeli Pill to Replace Colonoscopy on November 13, 2013 at 5:02 am
In August Given Imaging, an Israeli medical technology company, received FDA approval for their Pill Cam SB3 which will potentially replace colonoscopies in screening for colorectal cancer. Furthermor... […]
- Shares Of Given Imaging Undervalued With Recent Approvals And Pending Colon Pill on August 15, 2013 at 7:23 am
Shares of medical company Given Imaging (GIVN) traded up 7% on Tuesday after the approval of the company's PillCam SB3 in the United States. That approval, along with a recent deal in Japan, and sever... […]
via Bing News
